Inherited Alzheimer’s damage greater decades before symptoms appear

More Information

Media enquiries: Amanda Place at the Florey on 0411 204 526 orAnnie Rahilly at the University of Melbourne on 0432 758 734.

The progression of Alzheimer’s may slow once symptoms appear and do significant damage , according to a study investigating an inherited form of the disease.

In a paper published in the prestigious journal Science Translational Medicine, Professor Colin Masters from the Florey Institute of Neuroscience and Mental Health and University of Melbourne – and colleagues in the UK and US – have found rapid neuronal damage begins 10 to 20 years before symptoms appear.

“As part of this research we have observed other changes in the brain that occur when symptoms begin to appear. There is actually a slowing of the neurodegeneration,” said Professor Masters.Autosomal-dominant Alzheimer’s affects families with a genetic mutation, predisposing them to the crippling disease. These families provide crucial insight into the development of Alzheimer’s because they can be identified years before symptoms develop. The information gleaned from this group will also influence treatment offered to those living with the more common age-related version. Only about one per cent of those with Alzheimer’s have the genetic type of the disease.

The next part of the study involves a clinical trial. Using a range of imaging techniques (MRI and PET) and analysis of blood and cerebrospinal fluid, individuals from the US, UK and Australia will be observed as they trial new drugs to test their safety, side effects and changes within the brain.

“As part of an international study, family members are invited to be part of a trial in which two experimental drugs are offered many years before symptoms appear,” Prof Masters says. “It’s going to be very interesting to see how clinical intervention affects this group of patients in the decades before symptoms appear.”

The Florey is looking to recruit more participants in the Dominantly Inherited Alzheimer Network (DIAN) study. Those who either know they have a genetic mutation that causes autosomal-dominant Alzheimer’s or who don’t know their genetic status but have a parent or sibling with the mutation are invited to email:

Related content in Medicine and Health Science

The University of Melbourne is home to a new state of the art Virtual Reality (VR) biomechanical facility that is vastly improving our understanding of human movement and how to treat and prevent injuries.

University of Melbourne research reveals that one in four Americans report chemical sensitivity, with nearly half this group medically diagnosed with Multiple Chemical Sensitivities (MCS), suffering health problems from exposure to common chemical products and pollutants such as insect spray, paint, cleaning supplies, fragrances and petrochemical fumes.

Twelve Indigenous health leaders are embarking on a bold and innovative leadership program through the Melbourne Poche Centre for Indigenous Health at The University of Melbourne to tackle some of Australia’s long-term health problems.

Doctors will be better able to predict breast cancer risk thanks to pioneering work led by University of Melbourne researchers, who have identified heritable but non-genetic markers for breast cancer susceptibility.

SUBSCRIBE

FOR UoM STAFF

FEATURED EXPERT

Human rights and international law expert Professor Hilary Charlesworth, says that Australia's appointment to the UN Human Rights Council gives the country an opportunity to examine its own human rights record.